167 related articles for article (PubMed ID: 11083532)
21. Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison.
Mansueto M; Grimaldi A; Torbica A; Pepe G; Giovacchini G; Messa C; Fazio F
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):224-34. PubMed ID: 17538525
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
Verboom P; van Tinteren H; Hoekstra OS; Smit EF; van den Bergh JH; Schreurs AJ; Stallaert RA; van Velthoven PC; Comans EF; Diepenhorst FW; van Mourik JC; Postmus PE; Boers M; Grijseels EW; Teule GJ; Uyl-de Groot CA;
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1444-9. PubMed ID: 14579081
[TBL] [Abstract][Full Text] [Related]
24. [Decision tree sensitivity analysis for cost-effectiveness of chest FDG-PET in patients with a pulmonary tumor (non-small cell carcinoma)].
Kosuda S; Ichihara K; Watanabe M; Kobayashi H; Kusano S
Kaku Igaku; 1998 Jul; 35(6):395-404. PubMed ID: 9753918
[TBL] [Abstract][Full Text] [Related]
25. The solitary pulmonary nodule: aggressive excisional strategy.
Decamp MM
Semin Thorac Cardiovasc Surg; 2002 Jul; 14(3):292-6. PubMed ID: 12232872
[TBL] [Abstract][Full Text] [Related]
26. Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?
Hayashi K; Abe K; Yano F; Watanabe S; Iwasaki Y; Kosuda S
Ann Nucl Med; 2005 Jul; 19(5):393-8. PubMed ID: 16164196
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
[TBL] [Abstract][Full Text] [Related]
28. Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography.
Klose T; Leidl R; Buchmann I; Brambs HJ; Reske SN
Eur J Nucl Med; 2000 Oct; 27(10):1457-64. PubMed ID: 11083533
[TBL] [Abstract][Full Text] [Related]
29. Segmental
Spadafora M; Pace L; Mansi L
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):1-4. PubMed ID: 27695909
[No Abstract] [Full Text] [Related]
30. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
Halley A; Hugentobler A; Icard P; Porret E; Sobrio F; Lerochais JP; Bouvard G; Zalcman G; Agostini D
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1026-32. PubMed ID: 15877227
[TBL] [Abstract][Full Text] [Related]
31. [PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer].
Weber WA; Dietlein M; Hellwig D; Kirsch CM; Schicha H; Schwaiger M
Nuklearmedizin; 2003 Aug; 42(4):135-44. PubMed ID: 12937692
[TBL] [Abstract][Full Text] [Related]
32. Systematic review of the cost-effectiveness of positron-emission tomography in staging of non--small-cell lung cancer and management of solitary pulmonary nodules.
Cao JQ; Rodrigues GB; Louie AV; Zaric GS
Clin Lung Cancer; 2012 May; 13(3):161-70. PubMed ID: 22133290
[TBL] [Abstract][Full Text] [Related]
33. Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodules.
Gilbert FJ; Harris S; Miles KA; Weir-McCall JR; Qureshi NR; Rintoul RC; Dizdarevic S; Pike L; Sinclair D; Shah A; Eaton R; Jones J; Clegg A; Benedetto V; Hill J; Cook A; Tzelis D; Vale L; Brindle L; Madden J; Cozens K; Little L; Eichhorst K; Moate P; McClement C; Peebles C; Banerjee A; Han S; Poon FW; Groves AM; Kurban L; Frew A; Callister MEJ; Crosbie PA; Gleeson FV; Karunasaagarar K; Kankam O; George S
Thorax; 2022 Oct; 77(10):988-996. PubMed ID: 34887348
[TBL] [Abstract][Full Text] [Related]
34. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.
Divisi D; Di Tommaso S; Di Leonardo G; Brianzoni E; De Vico A; Crisci R
Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626
[TBL] [Abstract][Full Text] [Related]
35. Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.
Şahin E; Kara A; Elboğa U
Radiol Med; 2016 Dec; 121(12):944-949. PubMed ID: 27567614
[TBL] [Abstract][Full Text] [Related]
36. Prospective investigation of positron emission tomography in lung nodules.
Lowe VJ; Fletcher JW; Gobar L; Lawson M; Kirchner P; Valk P; Karis J; Hubner K; Delbeke D; Heiberg EV; Patz EF; Coleman RE
J Clin Oncol; 1998 Mar; 16(3):1075-84. PubMed ID: 9508193
[TBL] [Abstract][Full Text] [Related]
37. Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small-cell lung carcinoma in Japan.
Kosuda S; Ichihara K; Watanabe M; Kobayashi H; Kusano S
Ann Nucl Med; 2002 Jun; 16(4):263-71. PubMed ID: 12126096
[TBL] [Abstract][Full Text] [Related]
38. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
Gupta NC; Maloof J; Gunel E
J Nucl Med; 1996 Jun; 37(6):943-8. PubMed ID: 8683316
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
Bar-Shalom R; Kagna O; Israel O; Guralnik L
Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
Vriens D; Adang EM; Netea-Maier RT; Smit JW; de Wilt JH; Oyen WJ; de Geus-Oei LF
J Clin Endocrinol Metab; 2014 Sep; 99(9):3263-74. PubMed ID: 24873995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
